Beyond stroke therapy, neuroaid (a chinese herbal) has an effect on cognition and neurogenesis, a bibliometric study [version 2; peer review: 2 approved] [PDF]
F1000ResearchIntroduction NeuroAiD, also known as MLC601 or MLC901, is a Chinese herbal combination used worldwide for stroke treatment. It contains herbal components and five hewan components.
Dwi Arwandi Yogi Saputra +3 more
doaj +2 more sources
MLC901 for Moderate to Severe Traumatic Brain Injury: Pilot, Randomized, Double-Masked, Placebo- Controlled Trial [PDF]
Open Access Journal of Complementary & Alternative Medicine, 2020 Traumatic brain injury (TBI) has significant morbidity, mortality and is the major cause of disability in individuals younger than 35...
H. Pakdaman +7 more
semanticscholar +2 more sources
Translational Medicine in Acute Ischemic Stroke and Traumatic Brain Injury—NeuroAiD Trials, from Traditional Beliefs to Evidence-Based Therapy [PDF]
BiomoleculesAcute ischemic stroke (AIS) and traumatic brain injury (TBI) are two severe neurological events, both being major causes of death and prolonged impairment.
Narayanaswamy Venketasubramanian +2 more
doaj +2 more sources
The NeuroAiD II (MLC901) in Vascular Cognitive Impairment Study (NEURITES) [PDF]
Cerebrovascular Diseases, 2013 Background: A substantial proportion of patients after nondisabling stroke are cognitively impaired compared to age- and education-matched community-dwelling controls.
C. Chen +5 more
semanticscholar +5 more sources
Effect of MLC901 on Red Cell Distribution Width (RDW) in Acute Ischemic Stroke: Literature Review
Jurnal Biologi TropisAcute ischemic stroke is an acute episode of neurological dysfunction caused by focal infarction or damage that persists for ≥24 hours in the brain, spine, and retinal. Stroke is the second highest cause of death worldwide. The total prevalence of stroke
Muhammad Arya +4 more
semanticscholar +2 more sources
Integrative molecular simulations reveal NeuroAid II mechanisms in ischemic stroke through network pharmacology, molecular dynamics, and pharmacophore modeling [PDF]
Scientific ReportsIschemic stroke remains a major health challenge with limited treatment options. NeuroAid II (MLC901), a multi-herbal remedy, has shown clinical promise in post-stroke recovery, though its molecular mechanisms are unclear.
Doni Dermawan +4 more
doaj +2 more sources
Endothelial cell-derived extracellular vesicles induce pro-angiogenic responses in mesenchymal stem cells. [PDF]
FEBS Open BioHuman umbilical vein endothelial cell line‐derived small extracellular vesicles (EVs; <200 nm) (HU‐sEVs) were used as a pro‐angiogenic agent. They were characterized by evaluating morphology, size, and count. Chemical properties of HU‐sEVs were also investigated by antibody‐based and omics. All were based on MISEV criteria.
Abdik H +6 more
europepmc +2 more sources
The potential of MLC901 (NeuroAiD II™), a traditional Chinese medicine
Neuroscience Research Notes, 2019 Stroke, also known as cerebral ischemia, is a common neurological disease. The therapeutic potential of MLC901 (NeuroAiD II™) has been reported in clinical trials on traumatic brain injury as well as in animal and cell models.
Su-ping Huang +4 more
semanticscholar +3 more sources
Cost-effectiveness of MLC601 in post-stroke functional recovery compared with placebo - the CHIMES & CHIMES-E studies [PDF]
BMC Health Services ResearchBackground Despite progress in stroke therapy (e.g., revascularisation interventions by thrombolysis and/or thrombectomy, organised stroke care), many stroke survivors will have impairment of neurological function.
Christopher Li Hsian Chen +3 more
doaj +2 more sources